This school will focus on the contribution of gut-liver axis to a range of chronic liver diseases, the growing pertinence of antimicrobial resistance to cirrhosis, and manipulation of the gut microbiome as a novel approach to treatment (using faecal microbiota transplant amongst other techniques). This school aims to give an update over a number of key themes across the spectrum of the microbiome and liver disease, relevant to clinicians and scientists alike.

School Organisers:  Dr Roberta Forlano, Prof. Pinelopi Manousou, Prof Julian Marchesi, Dr. Benjamin Mullish, Prof. Debbie Shawcross, Prof. Mark Thursz and Prof. Palak Trivedi.

• To give an overview of what the gut microbiome is, and an introduction to methodologies to study it (including next generation sequencing, and other ‘omic’ technologies)
• To give an insight into the current understanding of the ‘gut liver axis’ to a range of chronic liver diseases
• To give an update on the burden of infectious disease to patients with chronic liver disease, including bacterial infections in alcoholic liver disease, and antimicrobial resistance.
• To give an insight into current understanding about routes of manipulating the gut microbiome/ gut liver axis as a novel approach to therapy in chronic liver diseases.

• Hepatologists
• Basic and translational scientists
• Clinical scientists